Dan Steiber, RPh, Specialty Pharmacy Times® Editor-In-Chief & Executive Vice President

Given the state of political affairs currently engulfing health care, our industry regularly gets vilified and is frequently a victim of misperception.

The meteoric rise in drug spending over the past 10 years has been driven by specialty therapeutics, while spending on traditional therapies has decreased.